Neuromarkers which can predict neurodevelopmental impairment among children with congenital heart defects after cardiac surgery: A systematic literature review

References

• Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics – 2014 update: a report from the American heart association. Circulation. 2014;129(3):e28–e292. doi:10.1161/01.cir.0000441139.02102.80.
   PubMed Web of Science ®Google Scholar
• Pironkova RP, Giamelli J, Seiden H, Parnell VA, Gruber D, Sison CP, Kowal C, Ojamaa K. Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med. 2017;14(1):228–38. doi:10.3892/etm.2017.4493.
   PubMed Web of Science ®Google Scholar
• Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 2013 May;131(5):e1502–8. doi:10.1542/peds.2012-3435.
   PubMed Web of Science ®Google Scholar
• Gaynor JW, Stopp C, Wypij D, Andropoulos DB, Atallah J, Atz AM, Beca J, Donofrio MT, Duncan K, Ghanayem NS, et al. Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics. 2015;135(5):816–25. doi:10.1542/peds.2014-3825.
   PubMed Web of Science ®Google Scholar
• Graham EM, Martin RH, Atz AM, Hamlin-Smith K, Kavarana MN, Bradley SM, Alsoufi B, Mahle WT, Everett AD. Association of intraoperative circulating-brain injury biomarker and neurodevelopmental outcomes at 1 year among neonates who have undergone cardiac surgery. J Thorac Cardiovasc Surg. 2019;157(5):1996–2002. doi:10.1016/j.jtcvs.2019.01.040.
   PubMed Web of Science ®Google Scholar
• Dimitropoulos A, McQuillen PS, Sethi V, Moosa A, Chau V, Xu D, Brant R, Azakie A, Campbell A, Barkovich AJ, et al. Brain injury and development in newborns with critical congenital heart disease. Neurology. 2013;81(3):241–48. doi:10.1212/WNL.0b013e31829bfdcf.
   PubMed Web of Science ®Google Scholar
• Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, Mussatto KA, Uzark K, Goldberg CS, Johnson WH, et al. American heart association congenital heart defects committee, council on cardiovascular disease in the young, council on cardiovascular nursing, and stroke council, neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American heart association. Circulation. 2012;126(9):1143–72. doi:10.1161/CIR.0b013e318265ee8a.
   PubMed Web of Science ®Google Scholar
• Chen XH, Huang S, Kerr D. Biomarkers in clinical medicine. IARC Sci Publ. 2011;(163):303-22.
   Google Scholar
• Majnemer A. Benefits of early intervention for children with developmental disabilities. Semin Pediatr Neurol. 1998;5(1):62–69. doi:10.1016/S1071-9091(98)80020-X.
   PubMedGoogle Scholar
• Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350(jan02 1):g7647. doi:10.1136/bmj.g7647.
   PubMedGoogle Scholar
• Briscoe S, Bethel A, Rogers M. Conduct and reporting of citation searching in Cochrane systematic reviews: a cross‐ sectional study. Res Syn Meth. 2020;11(2):169–80. doi:10.1002/jrsm.1355.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Cata JP, Abdelmalak B, Farag E. Neurological biomarkers in the perioperative period. Br J Anaesth. 2011;107(6):844-58.
   Google Scholar
• Cheng F, Yuan Q, Yang J, Wang W, Liu H: The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis. PLoS One. 2014;9:e106680.
   Google Scholar
• Vergine M, Vedovelli L, Simonato M, Tonazzo V, Correani A, Cainelli E et al. Perioperative Glial Fibrillary Acidic Protein Is Associated with Long-Term Neurodevelopment Outcome of Infants with Congenital Heart Disease. Children (Basel). 2021;8:655.
   Google Scholar
• Vedovelli L, Padalino M, Suppiej A, Sartori S, Falasco G, Simonato M et al. Cardiopulmonary-Bypass Glial Fibrillary Acidic Protein Correlates With Neurocognitive Skills. Ann Thorac Surg. 2018;106(3):792-798 .
   Google Scholar
• Bar-Yosef O, Greidinger D, Iskilova M, Hemi R, Tirosh T, Vardi A. Neurological deficit is predicted by S100B in children after cardiac surgery. Clin Chim Acta. 2018;481:56-60. .
   Google Scholar
• Trakas E, Domnina Y, Panigrahy A, Baust T, Callahan PM, Morell VO et al. Serum Neuronal Biomarkers in Neonates With Congenital Heart Disease Undergoing Cardiac Surgery. Pediatr Neurol.2017;72:56-61.
   Google Scholar
• Sanchez-de-Toledo J, Chrysostomou C, Munoz R, Lichtenstein S, Sao-Avilés CA, Wearden PD et al. Cerebral regional oxygen saturation and serum neuromarkers for the prediction of adverse neurologic outcome in pediatric cardiac surgery. Neurocrit Care.2014;;21(1):133-9.
   Google Scholar
• Florio P, Abella R, Marinoni E, Di Iorio R, Letizia C, Meli M et al. Adrenomedullin blood concentrations in infants subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. Clin Chem. 2008;54(1):202-6
   Google Scholar
• Robertson DR, Justo RN, Burke CJ, Pohlner PG, Graham PL, Colditz PB. Perioperative predictors of developmental outcome following cardiac surgery in infancy. Cardiol Young. 2014;14(4):389-95.
   Google Scholar
• Lardner D, Davidson A, McKenzie I, Cochrane A. Delayed rises in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth. 2004;14(6):495-500.
   Google Scholar
• Schmitt B, Bauersfeld U, Schmid ER, Tuchschmid P, Molinari L, Fanconi S et al. Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? Brain Dev. 1998;20(7):536-9.
   Google Scholar
• Grizzle R. Wechsler Intelligence Scale for Children. In: Encyclopedia of Child Behavior and Development. Mercer Publishing, Boston, Springer; 2011:1553–1555.
   Google Scholar
• Orsini A, Pezzuti L, Picone L. WISC-IV: Contributo Alla Taratura Italiana; Giunti O.S. Organizzazioni Speciali: Firenze, Italy, 2012.
   Google Scholar
• Davis JL, Matthews RN. NEPSY-II Review: Korkman M, Kirk U, Kemp S. San Antonio, Teas, United States: NEPSY—Second Edition (NEPSY-II); 2007.
   Google Scholar
• Bayley NB Scales of Infant and Toddler Development. 3rd ed San Antonio, TX: Harcourt Assessment Inc; 2006.
   Google Scholar
• Sparrow SS, Balla DA, Cichetti DV. Vineland Adaptive Behavior Scales. Circle Pines, MN: National Council on Measurement in Education; 1984.
   Google Scholar
• Kitchen L, Westmacott R, Friefeld S, MacGregor D, Curtis R, Allen A et al. The pediatric stroke outcome measure: a validation and reliability study. Stroke. 2012;43:1602–1608.
   PubMed Web of Science ®Google Scholar
• Fiser DH, Long N, Roberson PK, Hefley G, Zolten K, Brodie-Fowler M. Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments. Crit Care Med. 2000;28(7):2616–20.
   PubMed Web of Science ®Google Scholar
• Gosselin J, Gahagan S, Amiel-Tison C. The Amiel-Tison Neurological Assessment at Term: conceptual and methodological continuity in the course of follow-up. Ment Retard Dev Disabil Res Rev. 2005;11(1):34–51.
   PubMedGoogle Scholar
• Bayley N. Bayley Scales of Infant Development, 2nd ed. San Antonio, Texas, United States: The Psychological Corporation. Harcourt Brace and Company; 1993.
   Google Scholar
• Lee T, Chikkabyrappa SM, Reformina D, Mastrippolito A, Chakravarti SB, Mosca RS, Shaw G, Malhotra SP. Ubiquitin C-terminal hydrolase 1 and phosphorylated axonal neurofilament heavy chain in infants undergoing cardiac surgery: preliminary assessment as potential biomarkers of brain injury. World J Pediatr Congenit Heart Surg. 2018;9(4):412–18. doi:10.1177/2150135118762390.
   PubMed Web of Science ®Google Scholar
• Abella R, Varrica A, Satriano A, Tettamanti G, Pelissero G, Gavilanes AD, Zimmermann L, Vles H, Strozzi M, Pluchinotta F, et al. Biochemical markers for brain injury monitoring in children with or without congenital heart diseases. CNS Neurol Disord Drug Targets. 2015;14(1):12–23. doi:10.2174/1871527314666150116114648.
   PubMed Web of Science ®Google Scholar
• Gessler P, Pretre R, Hohl V, Rousson V, Fischer J, Dahinden C. CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock. 2004;22(6):513–20. doi:10.1097/01.shk.0000145939.54838.51.
   PubMed Web of Science ®Google Scholar
• Bembea MM, Rizkalla N, Freedy J, Barasch N, Vaidya D, Pronovost PJ, Everett AD, Mueller G. Plasma biomarkers of brain injury as diagnostic tools and outcome predictors after extracorporeal membrane oxygenation. Crit Care Med. 2015;43(10):2202–11. doi:10.1097/CCM.0000000000001145.
   PubMed Web of Science ®Google Scholar
• Hernández-García C, Rodríguez-Rodríguez A, Egea-Guerrero JJ. Brain injury biomarkers in the setting of cardiac surgery: Still a world to explore, Brain Injury. 2016;30:10–17.
   Google Scholar
• Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun. 2004;322(4):1111–22.
   PubMed Web of Science ®Google Scholar
• Snookes SH, Gunn JK, Eldridge BJ, Donath SM, Hunt RW, Galea MP et al. A systematic review of motor and cognitive outcomes after early surgery for congenital heart disease. Pediatrics. 2010;125(4):e818–27.
   PubMed Web of Science ®Google Scholar
• Brunetti MA, Jennings JM, Easley RB, Bembea M, Brown A, Heitmiller E, Schwartz JM, Brady KM, Vricella LA, Everett AD, et al. Glial fibrillary acidic protein in children with congenital heart disease undergoing cardiopulmonary bypass. Cardiol Young. 2013;11:1–9.
   Google Scholar
• Middlemas D. Brain derived neurotrophic factor. In: Enna SJ, David B editors. The comprehensive pharmacology reference. Amsterdam: Elsevier; 2007. p. 1–4.
   Google Scholar
• Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015;11(6):1164–78. doi:10.5114/aoms.2015.56342.
   PubMed Web of Science ®Google Scholar
• Bloise E, Pasquapina C, Dela Cruz C, Luisi S, Petraglia F, Fernando MR. Activin A in mammalian physiology. Physiol Rev. 2019;99(1):739–80. doi:10.1152/physrev.00002.2018.
   PubMed Web of Science ®Google Scholar
• Planel E, Richter KE, Nolan CE, Finley JE, Liu L, Wen Y, Krishnamurthy P, Herman M, Wang L, Schachter JB, et al. Anaesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci. 2007;27(12):3090–97. doi:10.1523/JNEUROSCI.4854-06.2007.
   PubMed Web of Science ®Google Scholar
• Pas´nik J, Cywin´ska-Bernas A, Moll J, Moll J, Sysa A, Zeman K. Alterations of metalloproteinases and their inhibitors concentrations in peripheral blood in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass. Przegl Lek. 2009;66:359–64.
   PubMedGoogle Scholar